论文检索
期刊
全部知识仓储预印本开放期刊机构
高级检索

PRSS1 c.455-33C>T突变在遗传性胰腺炎中的致病性分析OACSTPCD

Pathogenicity of PRSS1 c.455-33C>T mutation in hereditary pancreatitis

中文摘要英文摘要

目的 探讨人阳离子胰蛋白酶原(PRSS1)c.455-33C>T内含子杂合突变在遗传性胰腺炎(HP)中的致病性.方法 报告1例反复发作的急性胰腺炎病人,病人携带PRSS1 c.455-33C>T杂合突变,检索文献及网站初步分析其突变.提取健康对照者外周血基因组DNA,通过PCR扩增将PRSS1基因3号内含子序列、4号外显子序列和4号内含子序列与pSPL3载体连接构建质粒,命名为SWT;在SWT质粒的基础上通过定点突变的方法构建PRSS1 c.455-33C>T突变质粒,命名为S33;转染人胚肾细胞(Hek293T)后提取总RNA并进行RT-PCR及凝胶电泳,分析PRSS1 c.455-33C>T内含子突变是否引起PRSS1 mRNA剪切的改变进而引起HP.PCR扩增健康对照者外周血基因组DNA,将PRSS1基因3号内含子序列与增强子分析质粒pGL4.23连接,命名为EWT质粒;并在EWT质粒的基础上构建PRSS1 c.455-33C>T定点突变的质粒,命名为E33;将EWT、E33质粒转染Hek293T后利用双荧光素酶报告基因分析系统进行荧光素酶活性测定,分析PRSS1 c.455-33C>T内含子突变是否通过具有增强子功能引起PRSS1基因功能发生改变进而导致HP.结果 检索文献及网站确定PRSS1 c.455-33C>T突变为未报道的功能不明新突变.剪切分析实验显示,SWT和S33两组RT-PCR产物相同;双荧光素酶实验结果显示,E33组的荧光值低于EWT组,差异有统计学意义(t=12.23,P<0.001),E33组与EWT组相比没有增强子功能.结论 PRSS1 c.455-33C>T内含子突变不引起PRSS1 mRNA剪切的改变,也不具有PRSS1基因增强子功能,与PRSS1基因直接导致的HP无关.

Objective To investigate the pathogenicity of human cationic trypsinogen(PRSS1)c.455-33C>T intron hete-rozygous mutation in hereditary pancreatitis(HP).Methods This article reported a patient with recurrent acute pancreatitis carrying PRSS1 c.455-33C>T heterozygous mutation,which was analyzed based on related literature and websites.Peripheral blood genomic DNA was collected from healthy controls,and PCR amplification was used to connect the intron 3,exon 4,and in-tron 4 sequences of the PRSS1 gene with pSPL3 vector to construct SWT plasmid.The PRSS1 c.455-33C>T mutant plasmid,named the S33 plasmid,was constructed by site-directed mutagenesis on the basis of SWT plasmid.After human embryonic kidney Hek293T cells were transfected with the S33 plasmid,total RNA was extracted for RT-PCR and gel electrophoresis to investigate whether PRSS1 c.455-33C>T intron mutation caused the change of PRSS1 mRNA cleavage and led to HP.PCR amplification was performed for peripheral blood genomic DNA of healthy controls to connect the intron 3 sequence of the PRSS1 gene with pGL4.23 vector,namely the EWT plasmid,and the E33 plasmid of PRSS1 c.455-33C>T mutation was constructed based on the EWT plas-mid.After Hek293T cells were transfected with EWT and E33 plasmids,dual-luciferase reporter assay was used to measure luci-ferase activity,and the results were analyzed to determine whether PRSS1 c.455-33C>T intron mutation had enhancer function to cause the change of PRSS1 gene function and lead to HP.Results The search of relatedliterature and websites identified PRSS1 c.455-33C>T mutationas an unreported new mutation of unknown function.The shear analysis experiment showed that the SWT and S33 groups had identical products.The dual-luciferase reporter assay showed that the E33 group had a significantly lower fluorescence value than the EWT group(t=12.23,P<0.001).The E33 group showed no enhancer function compared with the EWT group.Conclusion PRSS1 c.455-33C>T intron mutation does not cause changes in PRSS1 mRNA cleavage and does not have the function of PRSS1 gene enhancer,and it is not associated with HP directly caused by the PRSS1 gene.

张雨;李晓宇;王佳;张文清;赵向忠;雷珂

青岛大学医学部,山东青岛 266071||青岛大学附属医院消化内科,山东青岛 266071青岛大学附属医院消化内科,山东青岛 266071青岛大学医学部,山东青岛 266071青岛大学医学研究中心,山东青岛 266071

临床医学

胰腺炎;人阳离子胰蛋白酶原;基因;突变

pancreatitis;human cationic trypsinogen;gene;mutation

《青岛大学学报(医学版)》 2024 (001)

23-27 / 5

国家自然科学基金资助项目(82270676);2021山东省研究生教学改革研究项目(SDYJG21110);青岛市中医药科技项目(2021-zyym26);青岛市医药卫生科研计划项目(2021-WJZD-191)

10.11712/jms.2096-5532.2024.60.024

评论

下载量:0
点击量:0